Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of This Novel Treatment Option
- 30 October 2009
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 17 (2), 484-491
- https://doi.org/10.1245/s10434-009-0777-x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Treatment of unresectable cholangiocarcinoma using yttrium‐90 microspheresCancer, 2008
- Intrahepatic CholangiocarcinomaAnnals of Surgery, 2008
- Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatmentHepatology, 2008
- CholangiocarcinomaThe Lancet, 2005
- The role of chemotherapy in cholangiocarcinomaAnnals of Oncology, 2005
- Combining Gemcitabine and Capecitabine in Patients With Advanced Biliary Cancer: A Phase II TrialJournal of Clinical Oncology, 2005
- Single-agent Gemcitabine in the Treatment of Advanced Biliary Tract Cancers: a Phase II StudyJapanese Journal of Clinical Oncology, 2005
- Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?Journal of Hepatology, 2004
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- The role of radiotherapy in the treatment of bile duct carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1990